General Session #2

Genetics

Saturday, April 12 | 10:45–11:45 a.m.


Tackling the VUS Problem

Heidi Rehm, Ph.D., Massachusetts General Hospital & Broad Institute of MIT and Harvard

As genetic testing and the content of each test has expanded, so has the rate of VUSs. Tackling this bold challenge will require innovative efforts in building and aggregating evidence for classifying variants, improving knowledgebases, evolving standards for variant classification, and reconsidering when and how we report VUSs. This talk will touch on various aspects of this bold challenge and how we, as a community, will tackle these challenges collaboratively.

 

See the full schedule

The program includes sessions, networking opportunities, industry spotlights and more.

View program

AMP Corporate Partners

Diamond Partner

Roche Diagnostics

Platinum Partner

Gold Partners

Abbvie
Amgen
Biotechne/Asuragen
Bristol Meyers Squibb
Illumina
Loxo
Merck
Pfizer

Silver Partners

Agilent
AstraZeneca